One year in review: Fibromyalgia

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 145-149

  Bazzichi, Laura ^a   Giacomelli, Camillo ^a   Consensi, Arianna ^a   Atzeni, Fabiola ^b   Batticciotto, Alberto ^c   Franco, Manuela Di ^d   Casale, Roberto ^e   Sarzi Puttini, Piercarlo ^c  

^a UNIVERSITY OF PISA   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Department of Internal Medicine   (Italy)

Author keywords

Assessment; Etiopathogenesis; Fibromyalgia; Therapies

Indexed keywords

AMITRIPTYLINE; DULOXETINE; HERBACEOUS AGENT; LEVACECARNINE; MAGNESIUM CHLORIDE; MILNACIPRAN; PALMIDROL; PLACEBO; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE;

ACTIMETRY; ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL (TOPIC); COMPLEX REGIONAL PAIN SYNDROME; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EARLY DIAGNOSIS; ELECTROACUPUNCTURE; FIBROMYALGIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GANODERMA LUCIDUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LASER EVOKED POTENTIAL; LOW DRUG DOSE; MOXIBUSTION; MUSIC THERAPY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL NEUROPATHY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; SLEEP QUALITY; TREATMENT DURATION; DISEASE MANAGEMENT; PATHOPHYSIOLOGY;

DISEASE MANAGEMENT; FIBROMYALGIA; HUMANS;

EID: 84977439169     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. WALITT B, URRúTIA G, NISHISHINYA MB, CANTRELL SE, HäUSER W: Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Sao Paulo Med J 2015; 133: 454.
2. PARK DJ, KANG JH, YIM YR et al.: Exploring genetic susceptibility to fibromyalgia. Chonnam Med J 2015; 51: 58-65.
3. ABLIN JN, BUSKILA D: Update on the genetics of the fibromyalgia syndrome. Best Pract Res Clin Rheumatol 2015; 29: 20-8.
4. INANIR A, YIGIT S, TEKCAN A, PINARLI FA, INANIR S, KARAKUS N: Angiotensin converting enzyme and methylenetetrahydrofolate reductase gene variations in fibromyalgia syndrome. Gene 2015; 564 :188-92.
5. RODRIGUEZ-RODRIGUEZ L, RAMóN LAMAS J, ABáSOLO L et al.: The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S33-40.
6. LITTLEJOHN G: Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat Rev Rheumatol 2015; 11: 639-48.
7. STAUD R: Cytokine and immune system abnormalities in fibromyalgia and other central sensitivity syndromes. Curr Rheumatol Rev 2015; 11: 109-15.
8. TRUINI A, GERARDI MC, DI STEFANO G et al.: Hyperexcitability in pain matrices in patients with fibromyalgia. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S68-72.
9. SEGURA-JIMéNEZ V, CAMILETTI-MOIRóN D, MUNGUíA-IZQUIERDO D et al.: Agreement between self-reported sleep patterns and actigraphy in fibromyalgia and healthy women. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S58-67.
10. ROEHRS T, DIEDERICHS C, GILLIS M et al.: Effects of reduced time in bed on daytime sleepiness and recovery sleep in fibromyalgia and rheumatoid arthritis. Psychosom Res 2015; 79: 27-31.
11. SáNCHEZ-DOMíNGUEZ B, BULLóN P, ROMáN-MALO L et al.: Oxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with Fibromyalgia. Mitochondrion 2015; 21: 69-75.
12. KIM J, LOGGIA ML, CAHALAN CM et al.: The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical/autonomic dysfunction. Arthritis Rheumatol 2015; 67: 1395-405.
13. LEVINE TD, SAPERSTEIN DS: Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients. Clin Rheumatol 2015; 34: 413-7.
14. DELL'OSSO L, BAZZICHI L, BARONI S et al.: The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome. Clin Exp Rheumatol 2015; (Suppl. 88): S109-16.
15. SKARE TL, PLAWIAK AC, VERONESE G, PAIVA ES, MESSIAS-REASON I, NISIHARA R: Pentraxin 3 levels in women with fibromyalgia. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S142.
16. PERNAMBUCO AP, SCHETINO LP, VIANA RS, CARVALHO LS, D'áVILA REIS D: The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S14-9.
17. MAINKA T, MAIER C, ENAX-KRUMOVA EK: Neuropathic pain assessment: update on laboratory diagnostic tools. Curr Opin Anaesthesiol 2015; 28: 537-45.
18. RAMíREZ M, MARTíNEZ-MARTíNEZ LA, HERNáNDEZ-QUINTELA E, VELAZCOCASAPíA J, VARGAS A, MARTíNEZ-LAVíN M: Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy. Semin Arthritis Rheum 2015; 45: 214-9.
19. DIAZ-PIEDRA C, CATENA A, SáNCHEZ AI, MIRó E, MARTíNEZ MP, BUELA-CASAL G: Sleep disturbances in fibromyalgia syndrome: the role of clinical and polysomnographic variables explaining poor sleep quality in patients. Sleep Med 2015; 16: 917-25.
20. MUNDT JM, CREW EC, KRIETSCH K et al.: Measuring Treatment Outcomes in Comorbid Insomnia and Fibromyalgia: Concordance of Subjective and Objective Assessments. J Clin Sleep Med 2015; 12: 215-23.
21. SALAFFI F, CIAPETTI A, GASPARINI S, ATZENI F, SARZI-PUTTINI P, BARONI M: Web/Internet- based telemonitoring of a randomized controlled trial evaluating the time-integrated effects of a 24-week multicomponent intervention on key health outcomes in patients with fibromyalgia. Clin Exp Rheumatol 2015; (Suppl. 88): S93-101.
22. van MIDDENDORP H, KOOL MB, van BEUGEN S, DENOLLET J, LUMLEY MA, GEENEN R: Prevalence and relevance of Type D personality in fibromyalgia. Gen Hosp Psychiatry 2016; 39: 66-72.
23. VILALTA-ABELLA F, GUTIéRREZ-MALDONADO J, PLA-SANJUANELO J: Development of a virtual environment based on the perceived characteristics of pain in patients with fibromyalgia. Stud Health Technol Inform 2015; 219: 158-62.
24. WALITT B, URRúTIA G, NISHISHINYA MB, CANTRELL SE, HäUSER W: Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Sao Paulo Med J 2015; 133: 454.
25. LEE YC, MASSAROTTI E, EDWARDS RR et al.: Effect of milnacipran on pain in patients with rheumatoid arthritis with widespread pain: a randomized blinded crossover trial. J Rheumatol 2016; 43: 38-45.
26. CORDING M, DERRY S, PHILLIPS T, MOORE RA, WIFFEN PJ: Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2015; 10: CD008244.
27. AHMED M, AAMIR R, JISHI Z, SCHARF MB: The effects of milnacipran on sleep disturbance in fibromyalgia: a randomized, doubleblind, placebo-controlled, two-way crossover study. J Clin Sleep Med 2016; 12: 79-86.
28. RICO-VILLADEMOROS F, SLIM M, CALANDRE EP: Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother 2015; 15: 1123-50.
29. DEL GIORNO R, SKAPER S, PALADINI A, VARRASSI G, COACCIOLI S: Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies. Pain Ther 2015; 4: 169-78.
30. MURAKAMI M, OSADA K, MIZUNO H, OCHIAI T, ALEV L, NISHIOKA K: A randomized, double- blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Arthritis Res Ther 2015; 17: 224.
31. ENGEN DJ, McALLISTER SJ, WHIPPLE MO et al.: Effects of transdermal magnesium chloride on quality of life for patients with fibromyalgia: a feasibility study. J Integr Med 2015; 13: 306-13.
32. ROTH T, BHADRA-BROWN P, PITMAN VW, RESNICK EM: Pregabalin Improves Fibromyalgia- Related Sleep Disturbance. Clin J Pain 2016; 32: 308-12.
33. ARNOLD LM, SARZI-PUTTINI P, ARSENAULT P et al.: Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study. J Rheumatol 2015; 42: 1237-44.
34. WHITE HD, BROWN LA, GYURIK RJ et al.: Treatment of pain in fibromyalgia patients with testosterone gel: Pharmacokinetics and clinical response. Int Immunopharmacol 2015; 27: 249-56.
35. LEOMBRUNI P, MINIOTTI M, COLONNA F et al.: A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S82-5.
36. ARGOFF CE, CLAIR A, EMIR B, WHALEN E, ORTIZ M, PAUER L: Prior opioid use does not impact the response to pregabalin in patients with fibromyalgia. Clin J Pain 2015 Mar 7 [Epub ahead of print].
37. COLLADO MATEO D, PAZZI F, DOMíNGUEZ MUñOZ FJ et al.: Ganoderma lucidum improves physical fitness in women with fibromyalgia. Nutr Hosp 2015; 32: 2126-35.
38. DIAS PA, GUIMARãES AB, ALBUQUERQUE ADE O, de OLIVEIRA KL, CAVALCANTE ML, GUIMARãES SB: Short term complementary and alternative medicine on quality of life in women with fibromyalgia. J Integr Med 2016; 14: 29-35.
39. SALEHI A, HASHEMI N, IMANIEH MH, SABER M: Chiropractic: Is it efficient in treatment of diseases? review of systematic reviews. Int J Community Based Nurs Midwifery 2015; 3: 244-54.
40. VAYVAY ES, TOK D, TURGUT E, TUNAY VB: The effect of laser and taping on pain, functional status and quality of life in patients with fibromyalgia syndrome: A placebo- randomized controlled clinical trial. J Back Musculoskelet Rehabil 2016; 29: 77-83.
41. ALPARSLAN GB, BABADAG B, öZKARAMAN A, YILDIZ P, MUSMUL A, KORKMAZ C: Effects of music on pain in patients with fibromyalgia. Clin Rheumatol 2016; 35: 1317-21.
42. LARSSON A, PALSTAM A, LöFGREN M et al.: Resistance exercise improves muscle strength, health status and pain intensity in fibromyalgia--a randomized controlled trial. Arthritis Res Ther 2015; 17: 161.
43. EFRATI S, GOLAN H, BECHOR Y et al.: Hyperbaric oxygen therapy can diminish fibromyalgia syndrome-prospective clinical trial. PLoS One 2015; 10: e0127012.
44. WANG C, McALINDON T, FIELDING RA et al.: A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial. Trials 2015; 16: 34.
45. SAñUDO B, CARRASCO L, de HOYO M, FIGUEROA A, SAXTON JM: Vagal modulation and symptomatology following a 6-month aerobic exercise program for women with fibromyalgia. Clin Exp Rheumatol 2015; 33 (Suppl. 88): S41-5.
46. ZAMUNéR AR, ANDRADE CP, FORTI M et al.: Effects of a hydrotherapy programme on symbolic and complexity dynamics of heart rate variability and aerobic capacity in fibromyalgia patients. Clin Exp Rheumatol 2015; (Suppl. 88): S73-81.
47. FAGERLUND AJ, HANSEN OA, ASLAKSEN PM: Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain 2015; 156: 62-71.